Hematopoietic and eosinophil-specific LNK(SH2B3) deficiency promotes eosinophilia and arterial thrombosis

2.

Vallejo-Vaz

AJ

,

Fayyad

R

,

Boekholdt

SM

, et al.

Triglyceride-rich lipoprotein cholesterol and risk of cardiovascular events among patients receiving statin therapy in the TNT trial

.

Circulation

.

2018

;

138

(

8

):

770

-

781

.

3.

Cannon

CP

,

Blazing

MA

,

Giugliano

RP

, et al.

Ezetimibe added to statin therapy after acute coronary syndromes

.

N Engl J Med

.

2015

;

372

(

25

):

2387

-

2397

.

4.

Sabatine

MS

,

Giugliano

RP

,

Keech

AC

, et al;

FOURIER Steering Committee and Investigators and Investigators

.

Evolocumab and clinical outcomes in patients with cardiovascular disease

.

N Engl J Med

.

2017

;

376

(

18

):

1713

-

1722

.

5.

Ridker

PM

,

Everett

BM

,

Thuren

T

, et al.

Antiinflammatory therapy with canakinumab for atherosclerotic disease

.

N Engl J Med

.

2017

;

377

(

12

):

1119

-

1131

.

6.

Tardif

JC

,

Kouz

S

,

Waters

DD

, et al.

Efficacy and safety of low-dose colchicine after myocardial infarction

.

N Engl J Med

.

2019

;

381

(

26

):

2497

-

2505

.

7.

Welsh

C

,

Welsh

P

,

Mark

PB

, et al.

Association of total and differential leukocyte counts with cardiovascular disease and mortality in the UK Biobank

.

Arterioscler Thromb Vasc Biol

.

2018

;

38

(

6

):

1415

-

1423

.

8.

Totani

L

,

Evangelista

V

.

Platelet-leukocyte interactions in cardiovascular disease and beyond

.

Arterioscler Thromb Vasc Biol

.

2010

;

30

(

12

):

2357

-

2361

.

9.

Niccoli

G

,

Sgueglia

GA

,

Conte

M

, et al.

Eosinophil cationic protein and clinical outcome after bare metal stent implantation

.

Atherosclerosis

.

2011

;

215

(

1

):

166

-

169

.

10.

Gudbjartsson

DF

,

Bjornsdottir

US

,

Halapi

E

, et al.

Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction

.

Nat Genet

.

2009

;

41

(

3

):

342

-

347

.

11.

Jacobsen

EA

,

Jackson

DJ

,

Heffler

E

, et al.

Eosinophil knockout humans: uncovering the role of eosinophils through eosinophil-directed biological therapies

.

Annu Rev Immunol

.

2021

;

39

:

719

-

757

.

12.

Zhao

X

,

Jiang

L

,

Xu

L

, et al.

Predictive value of in-hospital white blood cell count in Chinese patients with triple-vessel coronary disease

.

Eur J Prev Cardiol

.

2019

;

26

(

8

):

872

-

882

.

13.

Pongdee

T

,

Manemann

SM

,

Decker

PA

, et al.

Rethinking blood eosinophil counts: epidemiology, associated chronic diseases, and increased risks of cardiovascular disease

.

J Allergy Clin Immunol Glob

.

2022

;

1

(

4

):

233

-

240

.

14.

Sundström

J

,

Söderholm

M

,

Borné

Y

, et al.

Eosinophil cationic protein, carotid plaque, and incidence of stroke

.

Stroke

.

2017

;

48

(

10

):

2686

-

2692

.

15.

Ames

PR

,

Margaglione

M

,

Mackie

S

,

Alves

JD

.

Eosinophilia and thrombophilia in churg strauss syndrome: a clinical and pathogenetic overview

.

Clin Appl Thromb Hemost

.

2010

;

16

(

6

):

628

-

636

.

16.

Todd

S

,

Hemmaway

C

,

Nagy

Z

.

Catastrophic thrombosis in idiopathic hypereosinophilic syndrome

.

Br J Haematol

.

2014

;

165

(

4

):

425

.

17.

Marx

C

,

Novotny

J

,

Salbeck

D

, et al.

Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps

.

Blood

.

2019

;

134

(

21

):

1859

-

1872

.

18.

Hofheinz

K

,

Seibert

F

,

Ackermann

JA

, et al.

Formation of atherosclerotic lesions is independent of eosinophils in male mice

.

Atherosclerosis

.

2020

;

311

:

67

-

72

.

19.

Meng

Z

,

Zhang

S

,

Li

W

, et al.

Cationic proteins from eosinophils bind bone morphogenetic protein receptors promoting vascular calcification and atherogenesis

.

Eur Heart J

.

2023

;

44

(

29

):

2763

-

2783

.

20.

Thibord

F

,

Klarin

D

,

Brody

JA

, et al;

Global Biobank Meta-Analysis Initiative; Estonian Biobank Research Team; 23andMe Research Team; Biobank Japan; CHARGE Hemostasis Working Group

.

Cross-ancestry investigation of venous thromboembolism genomic predictors

.

Circulation

.

2022

;

146

(

16

):

1225

-

1242

.

21.

Bersenev

A

,

Wu

C

,

Balcerek

J

,

Tong

W

.

Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2

.

J Clin Invest

.

2008

;

118

(

8

):

2832

-

2844

.

22.

Takaki

S

,

Morita

H

,

Tezuka

Y

,

Takatsu

K

.

Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk

.

J Exp Med

.

2002

;

195

(

2

):

151

-

160

.

23.

Velazquez

L

,

Cheng

AM

,

Fleming

HE

, et al.

Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice

.

J Exp Med

.

2002

;

195

(

12

):

1599

-

1611

.

24.

Wang

W

,

Tang

Y

,

Wang

Y

, et al.

LNK/SH2B3 loss of function promotes atherosclerosis and thrombosis

.

Circ Res

.

2016

;

119

(

6

):

e91

-

e103

.

25.

Dou

H

,

Kotini

A

,

Liu

W

, et al.

Oxidized phospholipids promote NETosis and arterial thrombosis in LNK(SH2B3) deficiency

.

Circulation

.

2021

;

144

(

24

):

1940

-

1954

.

26.

Doyle

AD

,

Jacobsen

EA

,

Ochkur

SI

, et al.

Homologous recombination into the eosinophil peroxidase locus generates a strain of mice expressing Cre recombinase exclusively in eosinophils

.

J Leukoc Biol

.

2013

;

94

(

1

):

17

-

24

.

27.

Karcz

TP

,

Whitehead

GS

,

Nakano

K

, et al.

UDP-glucose and P2Y14 receptor amplify allergen-induced airway eosinophilia

.

J Clin Invest

.

2021

;

131

(

7

):

131

.

28.

Germic

N

,

Hosseini

A

,

Stojkov

D

, et al.

ATG5 promotes eosinopoiesis but inhibits eosinophil effector functions

.

Blood

.

2021

;

137

(

21

):

2958

-

2969

.

29.

Mack

EA

,

Stein

SJ

,

Rome

KS

, et al.

Trib1 regulates eosinophil lineage commitment and identity by restraining the neutrophil program

.

Blood

.

2019

;

133

(

22

):

2413

-

2426

.

30.

Kotini

AG

,

Chang

CJ

,

Chow

A

, et al.

Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia

.

Cell Stem Cell

.

2017

;

20

(

3

):

315

-

328.e7

.

31.

Lai

W

,

Xie

H

,

Liu

Y

, et al.

Human pluripotent stem cell-derived eosinophils reveal potent cytotoxicity against solid tumors

.

Stem Cell Reports

.

2021

;

16

(

7

):

1697

-

1704

.

32.

Pazdrak

K

,

Young

TW

,

Straub

C

,

Stafford

S

,

Kurosky

A

.

Priming of eosinophils by GM-CSF is mediated by protein kinase CbetaII-phosphorylated L-plastin

.

J Immunol

.

2011

;

186

(

11

):

6485

-

6496

.

33.

Thorne

KJ

,

Richardson

BA

,

Mazza

G

,

Butterworth

AE

.

A new method for measuring eosinophil activating factors, based on the increased expression of CR3 alpha chain (CD11b) on the surface of activated eosinophils

.

J Immunol Methods

.

1990

;

133

(

1

):

47

-

54

.

34.

Carmo

LA

,

Bonjour

K

,

Ueki

S

, et al.

CD63 is tightly associated with intracellular, secretory events chaperoning piecemeal degranulation and compound exocytosis in human eosinophils

.

J Leukoc Biol

.

2016

;

100

(

2

):

391

-

401

.

35.

Reichman

H

,

Rozenberg

P

,

Munitz

A

.

Mouse eosinophils: identification, isolation, and functional analysis

.

Curr Protoc Immunol

.

2017

;

119

:

14.43.1

-

14.43.22

.

36.

Zimmermann

N

,

McBride

ML

,

Yamada

Y

, et al.

Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils

.

Allergy

.

2008

;

63

(

9

):

1156

-

1163

.

37.

Uderhardt

S

,

Ackermann

JA

,

Fillep

T

, et al.

Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease

.

J Exp Med

.

2017

;

214

(

7

):

2121

-

2138

.

38.

Yu

C

,

Cantor

AB

,

Yang

H

, et al.

Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo

.

J Exp Med

.

2002

;

195

(

11

):

1387

-

1395

.

39.

Liu

Y

,

Carmona-Rivera

C

,

Moore

E

, et al.

Myeloid-specific deletion of peptidylarginine deiminase 4 mitigates atherosclerosis

.

Front Immunol

.

2018

;

9

:

1680

.

40.

Fuchs

TA

,

Brill

A

,

Duerschmied

D

, et al.

Extracellular DNA traps promote thrombosis

.

Proc Natl Acad Sci U S A

.

2010

;

107

(

36

):

15880

-

15885

.

41.

Carolan

EJ

,

Casale

TB

.

Degree of platelet activating factor-induced neutrophil migration is dependent upon the molecular species

.

J Immunol

.

1990

;

145

(

8

):

2561

-

2565

.

42.

Wardlaw

AJ

,

Moqbel

R

,

Cromwell

O

,

Kay

AB

.

Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils

.

J Clin Invest

.

1986

;

78

(

6

):

1701

-

1706

.

43.

Ueki

S

,

Melo

RC

,

Ghiran

I

,

Spencer

LA

,

Dvorak

AM

,

Weller

PF

.

Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans

.

Blood

.

2013

;

121

(

11

):

2074

-

2083

.

44.

Ueki

S

,

Tokunaga

T

,

Melo

RCN

, et al.

Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death

.

Blood

.

2018

;

132

(

20

):

2183

-

2187

.

45.

Adachi

T

,

Alam

R

.

The mechanism of IL-5 signal transduction

.

Am J Physiol

.

1998

;

275

(

3

):

C623

-

C633

.

46.

Mui

AL

,

Wakao

H

,

Harada

N

,

O'Farrell

AM

,

Miyajima

A

.

Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STAT5

.

J Leukoc Biol

.

1995

;

57

(

5

):

799

-

803

.

47.

Dellon

ES

,

Peterson

KA

,

Murray

JA

, et al.

Anti-siglec-8 antibody for eosinophilic gastritis and duodenitis

.

N Engl J Med

.

2020

;

383

(

17

):

1624

-

1634

.